CILE’s 4th Annual International Conference saw the research center rewarded for its evolving approach toward widening audience engagement and involvement for the most pressing topics of our time.

Read more here.

Elsevier Science recently published an article questioning why so many scientific researchers are choosing to work in Qatar. Prof. Omar El Agnaf, QBRI's new Acting Executive Director, was one of three researchers interviewed for the article.

The full article can be read here.

(image copyright 2016 Elsevier B.V.)

Metabolon, Inc., has entered a joint laboratory collaboration agreement with the Anti-Doping Laboratory Qatar (ADLQ), which operates an internationally accredited anti-doping laboratory, as well as toxicology and life sciences research services. ADLQ will establish Metabolon’s proprietary metabolomics platform in their Doha laboratory and serve academic and non-profit organizations throughout 13 countries in the Middle East.

Qatar Biomedical Research Institute (QBRI), part of Hamad Bin Khalifa University (HBKU), won the prestigious Arab Best Research Institution of the Year 2017 award, confirming the institute's position as a pioneer in the provision of healthcare solutions in Qatar, the region, and the world. The award was presented at a celebratory ceremony in Marrakech, Morocco.

Qatar Biomedical Research Institute (QBRI), part of Hamad Bin Khalifa University (HBKU), today signed a memorandum of understanding (MoU) with the Shafallah Center, a non-profit center dedicated to children with special needs. The agreement will pave the way for the two partners to undertake joint research activities, foster direct contact between specialists, as well as facilitate the use of facilities and equipment for research purposes.

A series of community activities and events were hosted by Qatar Biomedical Research Institute (QBRI), part of Hamad Bin Khalifa University’s (HBKU) in April, as part of the institute’s diligent efforts to promote and endorse a better understating of autism spectrum disorder (ASD). The ongoing, month-long public awareness campaign was in support of the 10th annual World Autism Awareness Day, which is marked worldwide in early April.

The New partnership will boost region’s first cell-therapy program to tackle diabetes

DOHA, October 1, 2018: The Qatar Biomedical Research Institute (QBRI), a premier research institute under Hamad Bin Khalifa University (HBKU) has signed a collaborative research and training agreement with the Harvard Stem Cell Institute (HSCI) in Boston, USA. The five-year initiative includes technical training and research in stem cell biology, which are essential for discovering viable treatments for diabetes.

Qatar Biomedical Research Institute concludes Memories Matter workshop to mark World Alzheimer’s Day

Doha, October 11, 2018 – Qatar Biomedical Research Institute (QBRI), a Hamad Bin Khalifa University (HBKU) research institute, held an interactive workshop entitled Memories Matter to mark World Alzheimer’s Day on September 25 at the HBKU Research Complex.

In light of its mission towards capacity building within the field of Autism Spectrum Disorder (ASD) service provision, Qatar Biomedical Research Institute (QBRI) – a research institute within Hamad Bin Khalifa University (HBKU) – recently concluded two specialized training courses that help professionals accurately assess and diagnose autism.

By developing an empowering, inspiring cycle of education and research that instills a capacity and drive to innovate from a young age – and provides a pathway of opportunity along which those who want to make a tangible difference can walk – QF is a landscape where new ground is continually being broken.